2. What is the advantage of using PBT-Profiler? 3. Discuss some of the limitations of PBT Profiler? 4. What are the obje
Posted: Mon May 16, 2022 10:19 pm
2. What is the advantage of using PBT-Profiler? 3. Discuss some of the limitations of PBT Profiler? 4. What are the objectives of the study? 5. Define the term (CEC) and provide an example? 6. What is meant by "pharmacokinetic behavior"? 7. Summarize the PST profile of the examined structures?
8. What is the use of Lipinski's rule of five (ROS)? List the 5 Rules? 9. Below are two structures A and B; with log P of 0.94, and -0.84 respectively. Evaluate the druglikness of these structures. Me NH Diaryl polyamide 6-Substituted indenoisoquinoline A B
8. What is the use of Lipinski's rule of five (ROS)? List the 5 Rules? 9. Below are two structures A and B; with log P of 0.94, and -0.84 respectively. Evaluate the druglikness of these structures. Me NH Diaryl polyamide 6-Substituted indenoisoquinoline A B